LBF20207TX02: Difference between revisions
No edit summary |
No edit summary |
||
Line 19: | Line 19: | ||
|Symbol=TXB2 | |Symbol=TXB2 | ||
|Biological Activity=Thromboxane B2 as s stable degradation product of thromboxane A2 shows diminishd biological activity [[Reference:Whittle_BJ:Moncada_S:,Br. Med. Bull.,1983,39,232|{{RelationTable/GetFirstAuthor|Reference:Whittle_BJ:Moncada_S:,Br. Med. Bull.,1983,39,232}}]]. | |Biological Activity=Thromboxane B2 as s stable degradation product of thromboxane A2 shows diminishd biological activity [[Reference:Whittle_BJ:Moncada_S:,Br. Med. Bull.,1983,39,232|{{RelationTable/GetFirstAuthor|Reference:Whittle_BJ:Moncada_S:,Br. Med. Bull.,1983,39,232}}]]. | ||
}} | |||
{{MassbankSpectra| | |||
UT000370 | |||
UT000371 | |||
UT000372 | |||
UT000373 | |||
UT000374 | |||
UT000375 | |||
UT000376 | |||
UT000377 | |||
UT000378 | |||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} |
Latest revision as of 00:00, 17 January 2014
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR2101 |
LipidMaps | LMFA03030002 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207TX02 |
Thromboxane B2 | |
---|---|
Structural Information | |
7- [Tetrahydro- (4S,6) -dihydroxy-2 R- (3S-hydroxy-trans-1-octenyl) -2H-pyran-3S-yl] -cis-5-heptenoic acid | |
| |
TXB2 | |
Formula | C20H34O6 |
Exact Mass | 370.23553882 |
Average Mass | 370.48036 |
SMILES | C(CC[C@H](O)C=C[C@@H](O1)[C@@H]([C@@H](CC1O)O)CC=CCCCC(O)=O)CC |
Physicochemical Information | |
95-96°C Hanessian_S et al. | |
[ α ]25 D =57.4°(C=0.26 ETHYL ACETATE) HanessianSet al. | |
ETHYL ACETATE Kelly RW et al. | |
Thromboxane B2 as a stable degradation product of bioactive but unstable thromboxane A2 is detected in the tissue where thromboxane A2 is produced Moncada_S et al.. | |
Hanessian_S et al. | |
The major urinary metabolite of tromboxane B2 is 2,3-dinor-thromboxane B2 Kindahl_H , and 11-dehydro-thromboxane B2 is known as a suitble parameter for monitoring thromboxane production in human Westlund_P et al.. 11-Hydroxythromboxane B2 dehydrogenase responsible for the 11-dehydro-thromboxane B2 production was identified as cytosolic aldehyde dehydrogenase Westlund_P et al.. | |
Thromboxane B2 as s stable degradation product of thromboxane A2 shows diminishd biological activity Whittle_BJ et al.. | |
Spectral Information | |
Mass Spectra | m/e 335, 317 HanessianSet al. |
UV Spectra | |
IR Spectra | FILM: ν 3380, 1705cm-1 HanessianSet al. |
NMR Spectra | 1H-NMR(CDCl3) : δ 5.86(m, 1H, 14-CH), 5.72(m, 1H, 13-CH), 5.46(m, 2H, 5,6-CH), 5.35 and 5.23(m, 1H, 11-CH), 4.41(m, 1H, 12-CH), 4.22(m, 1H, 15-CH), 4.11(m, 1H, 9-CH), 2.35(t, 2H, 2-CH2), 0.89(m, 3H, 20-CH3) KotovychGet al. |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|